Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 19622 | 432 | 26.6 | 50% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | CP MLR | Author keyword | 12 | 86% | 1% | 6 |
| 2 | HAM 3 | Author keyword | 9 | 83% | 1% | 5 |
| 3 | COMBINATORIAL PROTOCOL IN MULTIPLE LINEAR REGRESSION | Author keyword | 8 | 100% | 1% | 5 |
| 4 | ACTIVITY RATING | Author keyword | 6 | 80% | 1% | 4 |
| 5 | DRAGON DESCRIPTORS | Author keyword | 5 | 47% | 2% | 8 |
| 6 | CLUSTER SIGNIFICANCE ANALYSIS | Author keyword | 4 | 67% | 1% | 4 |
| 7 | COMBINATORIAL PROTOCOL IN MULTIPLE LINEAR REGRESSION CP MLR | Author keyword | 4 | 50% | 1% | 6 |
| 8 | GRADED CLASSIFICATION | Author keyword | 4 | 75% | 1% | 3 |
| 9 | ARYLPROPARGYL ETHERS OF PHENOLS | Author keyword | 3 | 100% | 1% | 3 |
| 10 | NITROBENZANTHRONES | Author keyword | 2 | 50% | 1% | 3 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | PREDICTING CARCINOGENICITY | 12 | 86% | 1% | 6 |
| 2 | BENZODIAZEPINE GABAA RECEPTORS | 11 | 69% | 2% | 9 |
| 3 | PHARMACEUTICAL PROBLEMS | 9 | 44% | 4% | 16 |
| 4 | 2 4 DIAMINO 5 SUBSTITUTED BENZYLPYRIMIDINES | 5 | 63% | 1% | 5 |
| 5 | REGIONS THEORY | 4 | 67% | 1% | 4 |
| 6 | RELATIONSHIP SAR ANALYSIS | 4 | 75% | 1% | 3 |
| 7 | TOPOLOGICAL DESCRIPTORS | 4 | 24% | 3% | 13 |
| 8 | POLYACENE CARCINOGENESIS | 3 | 57% | 1% | 4 |
| 9 | QUANTUM THEORIES | 3 | 57% | 1% | 4 |
| 10 | SYNTHETIC NEOLIGNANS | 3 | 100% | 1% | 3 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Neural networks as robust tools in drug lead discovery and development | 2004 | 47 | 119 | 34% |
| Visualization and Analysis of Drug Information on Adverse Reactions Using Data Mining Method, and Its Clinical Application | 2014 | 0 | 3 | 100% |
| Variable selection in QSAR models for drug design | 2008 | 12 | 82 | 24% |
| Prediction of enzyme activity with neural network models based on electronic and geometrical features of substrates | 2012 | 4 | 49 | 29% |
| Novel structure-activity insights from neural network models | 1995 | 1 | 2 | 100% |
| Applications of artificial neural networks to quantitative structure-activity relationships | 1996 | 15 | 48 | 44% |
| Neural networks as a method for elucidating structure-property relationships for organic compounds | 2003 | 4 | 128 | 33% |
| Application of neural networks in structure-activity relationships | 1999 | 42 | 188 | 19% |
| NONLINEAR MAPPING FOR STRUCTURE-ACTIVITY AND STRUCTURE-PROPERTY MODELING | 1993 | 20 | 35 | 31% |
| Prediction of protein retention times in anion-exchange chromatography systems using support vector regression | 2005 | 1 | 23 | 35% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | MOL MODELLING PHARMACOINFORMAT | 1 | 100% | 0.5% | 2 |
| 2 | MOL MODELING PHARMACOINFORMAT | 1 | 33% | 0.5% | 2 |
| 3 | AMINO ACIDES PEPTIDES PROT L P | 1 | 50% | 0.2% | 1 |
| 4 | BIOMED MAT PROGRAM | 1 | 50% | 0.2% | 1 |
| 5 | BIOMED PL | 1 | 50% | 0.2% | 1 |
| 6 | CNRS URA 463 | 1 | 50% | 0.2% | 1 |
| 7 | NEURO HEURIST | 1 | 50% | 0.2% | 1 |
| 8 | ORGAN SYNTH COAL CHEM | 1 | 12% | 0.9% | 4 |
| 9 | HLTH SUPERVIS | 1 | 22% | 0.5% | 2 |
| 10 | NEW LEADS | 0 | 33% | 0.2% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000230926 | THREE DIMENSIONAL HOLOGRAPHIC VECTOR OF ATOMIC INTERACTION FIELD 3D HOVAIF//COMFA//3D QSAR |
| 2 | 0.0000198797 | META LEVEL INFERENCE//P TOLUENE SULFONYL CHLORIDE//CEREBRAL VASODILATOR |
| 3 | 0.0000156509 | OPTIMAL DESCRIPTOR//CORAL SOFTWARE//MIA QSAR |
| 4 | 0.0000129687 | COMPUTER ASSISTED STRUCTURE ELUCIDATION//STRUCTURE GENERATOR//COMPUTER ASSISTED INTERPRETATION |
| 5 | 0.0000123106 | FLIP REGRESSION//ORBITAL NODES//BENZODIAZEPINE RECEPTOR ACTIVITY |
| 6 | 0.0000114478 | MULTIVARIATE SPLINE INTERPOLATION//SPRINGBOARD BUSINESS//ASSOCIATING NETWORKS |
| 7 | 0.0000105222 | TOMOCOMD CARDD SOFTWARE//CHEM BIOACT//UNIDAD INVEST DISENO FARMACOS CONECTIVIDAD MOL |
| 8 | 0.0000096124 | B IT//LIFE SCI INFORMAT//LIMES PROGRAM UNIT CHEM BIOL MED CHEM |
| 9 | 0.0000096009 | SAR AND QSAR IN ENVIRONMENTAL RESEARCH//TETRAHYMENA PYRIFORMIS//EXCESS TOXICITY |
| 10 | 0.0000085143 | EXCELLENCE ELE OCHEM//ELECTRODE POTENTIALS//ANTICOAGULANT COMPOUND |